Co-Operation Opportunities within Swiss Biotech

Besides publication in the different media as listed below, the Swiss Biotech Association offers co-operation opportunities to enhance your visibility in the biotech community.

Further information

List of publications with advertising opportunities (data as per end of 2009 - not representative):


Journal CirculationGeographic 
Distribution 
Customer
Segments 
American Biotech Laboratory  50'000  USA  22% biophysics,
19% biochemistry,
17% chemistry,
11% biotech
American Laboratory   70'000  USA/Canada  21% chemistry,
15% environmentals / analytics,
15% pharma
Bio Tech International  24'000  74% Europe,
18% Asia 
12% pharma,
13% molecular biology,
11% biochemistry
Bio-IT World     
BioExecutive International  14'000  79% North America,
21% Europe 
53% biopharmaceuticals / biotech,
19% clinical research
BIOforum  15'000  90% DE  35% pharma,
28% biotech,
12% university
BIOforum Europe  26'000  20% DE,A,CH,
18% UK,
22% Scandinavia,
11% France 
35% biotech,
28% pharma/food/cosmetics,
12% university
Biopharm International  30'000  74% North America,
17% Europe,
7% Asia 
33% biopharm,
23% pharma,
10% research
BioProcess International  30'000  67% USA/CDN,
33% EU 
41% biopharm,
10% clinical research,
9% biotech
BioScience Technology  55'000  USA  22% university,
18% private research,
17% pharma,
16% biotech
BioTechniques  80'000  76% USA/Cdn,
20% Europe,
2% Asia 
16% molecular biology,
14% biochemistry,
12% cell biology,
11% microbiology
Biotechnologies & Finances     
cav - chemie-anlagen + verfahren  35'000  D/CH/A  55% chemistry/pharma,
12% plant manufacture
Chemanager   43'000  D/CH/A  51% chemistry,
33% biotech
Chemanager Europe  15'000  18% UK,
25% D/CH/A,
13% F,
9% Benelux,
8% Eastern Europe,
8% I,
6% Scandinavia,
5% E/P 
51% chemistry,
33% biotech
Chemie plus  13'000  CH 
Chemische Rundschau  12'000  CH  59% chemistry,
14% biotech
CITplus  26'000  D/CH/A  41% chemistry,
30% engineering,
9% pharma
clb - Chemie in Labor und Biotechnik   5'000  D/CH/A 
Contract Pharma  20'000  80% USA  39% pharma,
10% CMO,
19% CRO
Contract Services Europe     
cpp chemical plants + processing  25'000  67% Europe,
25% Asia,
7% Americas 
55% chemistry / pharma,
12% plants
Drug Discovery & Development  35'000  95% USA  44% pharma,
23% biotech,
7% biopharm
European Biotechnology News  15'000  91% Europe  35% pharma,
19% suppliers,
18% university,
15% research
European Pharma Manufacturer  13'000  30% UK,
14% F,
13% D,
11% Scandinavia 
Forschung und Diagnostik  8'000  D/CH/A  42% medical,
20% pharma
GEN  80'000  70% USA  29% cell culture,
28% genomics,
28% separation
GIT Labor-Fachzeitschrift  25'000  D/CH/A  35% chemistry,
18% pharma,
11% university,
10% biotech
GIT Laboratory Journal Europe  27'000  22% UK/IR,
20% D/A/CH,
13% Scandinavia,
11% F,
10% Benelux 
35% chemistry,
19% pharm,
6% food,
5% biotech
GIT ReinraumTechnik  10'000  D/CH/A  25% pharma,
11% food,
8% biotech
GIT Separation  25'000  D/CH/A  39% chemistry,
21% pharma,
13% biotech,
13% university
GIT Steriltechnik   10'000  D/CH/A  30% pharma,
21% biotech,
17% food,
13% medical,
9% cosmetic
Industrial Biotechnology  4'000   
International Labmate  38'000  78% EU,
21% middle east 
46% industry,
37% hospital,
14% university
Journal of Biomoldecular Screening     
Journal of the Association of Lab Automation     
Lab Asia  25'000  17% China,
11% India,
10% Malaysia,
8% Taiwan,
8% Korea,
7% Australia 
52% industry,
37% hospital,
8% government
LabBusiness  25'000  Canada  31% chemical/pharma,
29% environmental,
27% food
Labmate UK  10'000  UK  49% industry,
32% hospitals
Labo  5'000  D/CH/A  21% chemistry / biotech,
15% university
Laboratorio y Analisis  27'000  36% Mexico,
14% Argentina,
9% Brazil,
8% Colombia,
7% Chile,
4% Venezuela 
31% chemistry,
20% food,
15% medical,
10% processing
Laborjournal  258000  D/CH/A  29% universities,
26% industry
Laborpraxis  23'000  D/CH/A  39% chemistry / pharma,
13% university,
5% clinical labs
LaborpraxisChina  10'000   
Laborwelt  20'000  D/CH/A  37% university,
23% research,
13% pharma / biotech
Lebensmittel & Biotechnologie  2'000  80% A,
 
Nature  60'000  55% Americas,
30% Europe,
15% Asia 
58% university,
12% industries
Nature biotech  17'000  90% North-America  23% molecular biology,
13% genomics,
8% microbiology
Nature Cell Biology  3'000  41% Americas,
39% Europe 
Nature Chemical Biology     
Nature Drug Discovery Reviews  10'000  55% Americas,
35% Europe,
10% Asia 
25% biotech,
21% pharma,
18% university,
11% consultants
Nature Genetics  6'000  56% Americas,
18% Europe 
50% research,
40% medical,
10% pharma / biotech
Nature Immunology  3'000  46% Americas,
20% Europe 
Nature Medicine  11'000  58% USA,
17% Europe 
70% university / medical,
29% pharma / biotech
Nature Methods  60'000  72% USA,
22% Europe 
54% pharma / biotech,
46% university
Noticias tecnicas  26‘000  78% South America,
22% E 
21% chemistry,
13% biochemistry,
10% analytics,
10% food,
10% biotech
PDA Letter  10'000    48% pharma,
23% biopharma,
11% consultants
Pharma + Food  10'000  D/CH/A  45% pharma,
15% food,
6% engineering
Pharma International     
Pharma Manufacturing   5'000  33% UK,
10% D/CH/A,
7%I,
5% Ost-EU 
80% pharma,
20% suppliers
Pharma Processing  31‘000  USA  79% pharma,
6% medical,
6% consulting,
5% university
Pharmaceutical Engineering  21'000  62% USA,
7% UK,
 
28% engineering,
28% pharma,
10% biotech,
9% supplier
Pharmaceutical Science & Technology Today  2'000  51% Europe,
37% USA,
12% Asia 
62% pharma / biotech,
24% university
Pharmaceutical Technology   34'000  USA  68% pharma / biopharma,
7% research,
6% university
Pharmaceutical Technology Asia  5'000  27% China,
24% Japan,
9% Korea,
7% India,
5% AUS,
 
Pharmaceutical Technology Europe  18‘000  21% UK,
17% D/CH/A,
13% F,
10% Scandinavia,
7% I,
6% E,
5% NL,
5% Eastern Europe  
69% pharma,
11% contract services,
7% medical
Pristine Processing  20'000  USA  36% pharma,
14% biotech,
11% food
Process  24'000  D/CH/A  50% chemistry / pharma,
29% engineering
Process China  30'000   
Process PharmaTEC  11'000  D/CH/A  46% pharma / chemistry,
13% food,
10% engineering,
9% university,
8% research
Process PharmaTEC international  15'000  26%D/CH/A,
16% Americas,
11% Asia,
8% I,
5% Scandinavia,
5% I 
46% pharma / chemistry,
13% food,
10% engineering,
9% university,
8% research
Process worldwide  25'000   
Schreening - Trends in Drug Discovery  10'000  39% D/CH/A,
24% UK,
13% F/B,
12% Scandinavia 
59% pharma,
20% biotech,
15% research
Transkript  10‘000  D/CH/A  28% biotech,
25% university,
17% suppliers,
18% research
UK Laboratory 17‘500  UK  18% analytics,
14% chemistry,
9% biochemistry,
7% biotech,
7% pharma


Community Login







Harlan Laboratories Ltd.

Bachem Holding AG

loroch.ch

 Wissenschaft im Gespraech | Den Naturwissenschaften fehlt der Nachwuchs | Schweizer Radio DRS

The potential in the land

LRC TriCEPS™ technology

BBC - End of Drug Discovery